Table I. Patient demographics.

Category	Total	Non-TE patients	TE patients
Number of patients	326	296	30
Sex, male, n (%)	168 (52%)	156 (53%)	12 (40%)
Age at NS diagnosis, years, median (range)*	6.5 (0-20.7)	6.2 (0-20.7)	13.8 (1-20.3)
Age ≥ 12 years at NS diagnosis, n (%)†	99 (30%)	80 (27%)	19 (63%)
Age at TE diagnosis, years, median (range)			15.2 (1-21.6)
Race, n (%)
African-American	68 (21%)	60 (20%)	8 (27%)
Caucasian	224 (69%)	204 (69%)	20 (67%)
Other	34 (10%)	32 (11%)	2 (7%)
NS category, n (%)*
Primary NS	244 (75%)	228 (77%)	16 (53%)
Secondary NS	82 (25%)	68 (23%)	14 (47%)
Follow-up time, years, median (range)	3.7 (0-20.8)	3.7 (0-20.8)	3.7 (0.3-14)
Peak uPr:Cr, median (range)*	10.0 (2.1-307.7)	9.8 (2.1-307.7)	14.2 (3.9-294.7)
Serum albumin nadir, median (range)	1.9 (0.6-3)	1.9 (0.6-3)	1.8 (1-2.7)
Previous history of TE, n (%)†	5 (2%)	1 (0.3%)	4 (13%)
Membranous histology, n (%)*,s‡	32 (10%)	24 (8%)	8 (27%)

Comparison between patients without and with TEs.

^*P < .01.

^†P < .0001.

^‡Class V SLE or MN.